Back to search

National and Kapodistrian University of Athens

Οστικός μεταβολισμός σε διαταραχές της θυρεοειδικής λειτουργίας

Abstract

dc:description

The thyroidopathies associated with abnormal thyroid hormone levels (either high or low) have a determinant impact on bone metabolism. The therapeutic correction of such situations seems to restore normal bone function. The aim of this thesis was to evaluate the medium-term correspondence of the skeletal system after therapeutic restoration of normal thyroid levels in hyper and hypothyroid patients. For this purpose, we monitored the trimestrial change of the contemporary bone markers and the semestrial change of the bone density in 52 women with thyroidopathy, for a total period of two years. These patients were distributed in 4 subgroups (A: 19 patients at the age of 35.9±13.8 years with clinical hyperthyroidism, B: 6 patients, 42.3±11.3 years, with endogenous subclinical hyperthyroidism, C: 14 patients, 44.9±11 years, with clinical hypothyroidism and D: 13 patients, 48.2±10.3 years, with subclinical hypothyroidism). All groups, with the exception of group B, had some kind of therapeutic intervention to achieve normal thyroid function. The objective of the therapeutic intervention was achieved in all subgroups by the first trimester of follow-up. In clinically hyperthyroid patients, the reduction of free Τ4 was accompanied by reduction in the corrected calcium (Ca (corr) p<0.01), increase of parathyroid hormone (PTH p<0.01), continuous reduction of osteoclastic markers (serum ΝΤΧ p<0.01, urine ΝΤΧ p<0.05) and increase in bone specific alkaline phosphatase (bsALP p<0.05) by the first trimester of follow-up. Bone Gla Protein began to decrease constantly 6 months after treatment initiation and thereforth (BGP p<0.05). Calcium remained in lower levels throughout the study, while PTH and bsALP began to decrease after a half-year period. In the same interval, 25 hydroxyvitamine D decreased in an opposite manner (p<0.01) in relation to PTH, and the active metabolite, 1,25 dihydroxyvitamine D, increased (p<0.05). In our study group of hyperthyroid patients a change in calcitonin, insulin growth factor 1 (IGF -1), tumor necrosis factor a (TNFa) and leptin was not observed, while interleukin 6 (IL -6) decreased in a subgroup of patients with high serum levels at baseline. These changes were followed by an increase in the bone mineral density of the femur neck by the first year of follow-up (p < 0.01). No change was observed in subgroup B. Subgroup C, as well as subgroup D, presented similar changes of markers during the study period. PTH did not present statistically important fluctuations, while the osteoclastic markers showed a progressive increase, statistically significant after 18 months of intervention (p<0.01).

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Αλουμανής, Κυριάκος
  • Aloumanis, Kyriakos

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/5812

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Αλουμανής, Κυριάκος; Aloumanis, Kyriakos. Οστικός μεταβολισμός σε διαταραχές της θυρεοειδικής λειτουργίας. National and Kapodistrian University of Athens, 2007. http://hdl.handle.net/10442/hedi/5812